Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress
2023 | journal article; overview. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress
Ehrenreich, H. ; Gassmann, M.; Poustka, L.; Burtscher, M.; Hammermann, P.; Sirén, A. & Nave, K.-A. et al. (2023)
Neuroprotection,. DOI: https://doi.org/10.1002/nep3.15
Documents & Media
Details
- Authors
- Ehrenreich, Hannelore ; Gassmann, Max; Poustka, Luise; Burtscher, Martin; Hammermann, Peter; Sirén, Anna‐Leena; Nave, Klaus-Armin ; Miskowiak, Kamilla
- Issue Date
- 2023
- Journal
- Neuroprotection
- Project
- TRR 274: Checkpoints of Central Nervous System Recovery
TRR 274 | C01: Oligodendroglial NMDA receptors and NMDAR1 autoantibodies as determinants of axonal integrity in neuropsychiatric disease - Working Group
- RG Ehrenreich (Clinical Neuroscience)
RG Nave (Neurogenetics) - ISSN
- 2770-730X
